Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of anti-inflammatory and analgesic agents. Its structure supports the creation of compounds with enhanced metabolic stability due to the presence of the trifluoromethoxy group. Commonly employed in the preparation of selective COX-2 inhibitors and other bioactive molecules where fluorinated aromatic rings improve potency and pharmacokinetic properties. Also utilized in agrochemical research for designing novel herbicides and pesticides with improved environmental stability.